Physician profile
Patrick P Lin
NPI 1144325747
$15,917.79
in general payments reported to CMS, 2019-2025
9 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,043 · 2020: $7,181 · 2021: $1,840 · 2022: $1,334 · 2023: $2,783 · 2024: $489 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $851 · Travel and Lodging: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $850.71 |
| Travel and Lodging | $669.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $6,820.38 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $6,549.96 | 2019-2023 | |
| Stryker Corporation | $1,227.44 | 2019-2025 | Aequalis Perform |
| Onkos Surgical, INC. | $621.92 | 2019-2025 | Eleos Limb Salvage System |
| Osteocentric Technologies, INC. | $275.25 | 2022 | |
| Illuminoss Medical, INC. | $168.46 | 2022 | |
| Sanara Medtech INC. | $163.39 | 2021-2022 | |
| Medinc of Texas | $46.93 | 2025 | |
| Carbofix Orthopedics INC | $44.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.